Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrakumar Shanmugam

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Bioinformation|June 12, 2026
Paradigm shift in utilization of blood and blood components during COVID pandemic among pregnant women in IndiaSaritha Karre, Anitha Sunkara, Neelima Manda, et al.
Journal of Gastrointestinal Oncology|March 2, 2013
Socioeconomic status, p53 abnormalities, and colorectal cancerEmily Vogtmann, Chandrakumar Shanmugam, Venkat R Katkoori, et al.
Biomarkers in Medicine|October 16, 2010
miRNAs as biomarkers for management of patients with colorectal cancerUpender Manne, Chandrakumar Shanmugam, Liselle Bovell, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Development and progression of colorectal neoplasiaUpender Manne, Chandrakumar Shanmugam, Venkat R Katkoori, et al.
Pathology, Research and Practice|September 26, 2020
COVID-2019 - A comprehensive pathology insightChandrakumar Shanmugam, Abdul Rafi Mohammed, Swarupa Ravuri, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
miRNAs are stable in colorectal cancer archival tissue blocksLiselle Bovell, Chandrakumar Shanmugam, Venkat R Katkoori, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 12, 2007
p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behaviorChandrakumar Shanmugam, Venkat R Katkoori, Nirag C Jhala, et al.
BMJ Open|April 22, 2022
Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemicChandrakumar Shanmugam, Michael Behring, Vishwas Luthra, et al.
Cancer|June 22, 2010
Prognostic value of mucin 4 expression in colorectal adenocarcinomasChandrakumar Shanmugam, Nirag C Jhala, Venkat R Katkoori, et al.
Current Colorectal Cancer Reports|June 20, 2017
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and PerspectiveUpender Manne, Trafina Jadhav, Balananda-Dhurjati Kumar Putcha, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Bioinformation|June 12, 2026
Paradigm shift in utilization of blood and blood components during COVID pandemic among pregnant women in IndiaSaritha Karre, Anitha Sunkara, Neelima Manda, et al.
Journal of Gastrointestinal Oncology|March 2, 2013
Socioeconomic status, p53 abnormalities, and colorectal cancerEmily Vogtmann, Chandrakumar Shanmugam, Venkat R Katkoori, et al.
Biomarkers in Medicine|October 16, 2010
miRNAs as biomarkers for management of patients with colorectal cancerUpender Manne, Chandrakumar Shanmugam, Liselle Bovell, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Development and progression of colorectal neoplasiaUpender Manne, Chandrakumar Shanmugam, Venkat R Katkoori, et al.
Pathology, Research and Practice|September 26, 2020
COVID-2019 - A comprehensive pathology insightChandrakumar Shanmugam, Abdul Rafi Mohammed, Swarupa Ravuri, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
miRNAs are stable in colorectal cancer archival tissue blocksLiselle Bovell, Chandrakumar Shanmugam, Venkat R Katkoori, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 12, 2007
p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behaviorChandrakumar Shanmugam, Venkat R Katkoori, Nirag C Jhala, et al.
BMJ Open|April 22, 2022
Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemicChandrakumar Shanmugam, Michael Behring, Vishwas Luthra, et al.
Cancer|June 22, 2010
Prognostic value of mucin 4 expression in colorectal adenocarcinomasChandrakumar Shanmugam, Nirag C Jhala, Venkat R Katkoori, et al.
Current Colorectal Cancer Reports|June 20, 2017
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and PerspectiveUpender Manne, Trafina Jadhav, Balananda-Dhurjati Kumar Putcha, et al.
Pageof 3